Detailed price information for Knight Therapeutics Inc (GUD-T) from The Globe and Mail including charting and trades.
The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, 2024, compared to a net loss of approximately $11.3 million, or $0.48 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback